The study is a federally funded systematic review and meta-analysis published in the American Journal of Psychiatry. The systematic review included 19 studies and the meta-analysis included 14. Researchers examined 19 clinical trials in which people with depression and high inflammation received various anti-inflammatory drugs or placebo for periods lasting up to 12 weeks.
Overall, anti-inflammatory treatments reduced depressive symptoms and eased anhedonia, the inability to feel pleasure. The analysis also found no increase in serious side effects among people who received anti-inflammatory drugs, a result that supports further investigation of anti-inflammatory approaches in selected patients.
Co-first author Annelise Madison, assistant professor of clinical psychology and affiliate member in the University of Michigan Eisenberg Family Depression Center, said: “This is an important finding that has the potential to make the emerging field of immunopsychiatry more relevant.” Immunopsychiatry studies connections between the immune system and mental health. The authors cautioned that these drugs are not approved by the FDA to treat depression, so psychiatric use would currently be off-label.
Madison suggested the results may help explain earlier mixed findings about anti-inflammatory treatments, because trials that did not select people by inflammatory status could miss benefits in a mixed group. Additional researchers from Harvard University and Emory University contributed to the work. Support came from the National Institute for Mental Health, a L.I.F.E. Foundation Research Grant, Harvard University’s Mind Brain Behavior Interfaculty Initiative, and the Massachusetts General Hospital Translational Clinical Research Center’s Early Career Investigator Award. Source: University of Michigan; appeared on Futurity.
Difficult words
- systematic review — Study that collects and evaluates many research papers
- meta-analysis — Statistical summary combining results from studies
- inflammation — Body's immune response causing redness or swelling
- anhedonia — Inability to feel pleasure or enjoyment
- immunopsychiatry — Study of links between the immune system and mental health
- off-label — Use of a drug for an unapproved purpose
- placebo — A substance with no active medical effect
- clinical trial — Research study testing a treatment in peopleclinical trials
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think doctors should test patients for inflammation before trying anti-inflammatory treatments for depression? Why or why not?
- What benefits and risks do you see in using anti-inflammatory drugs off-label for mental health conditions? Give reasons.
- How could future research build on these results to identify which patients might benefit most?
Related articles
High-fat diet lets gut bacteria reach mouse brains
Emory University researchers found that a short high-fat diet can let live gut bacteria travel to the brain in mice. The bacteria moved along the vagus nerve; returning to a normal diet reduced this effect and researchers call for more study.
Tanzania fights rabies with mass dog vaccination
Tanzania is working to stop human rabies by vaccinating dogs, improving surveillance and keeping vaccines cold. High vaccine costs, remote villages and lack of electricity remain challenges, but local and international efforts are growing.
Do low‑calorie sweeteners affect blood sugar and health?
Researchers reviewed trials and large studies on non‑nutritive sweeteners and found signals of worse blood sugar control and possible metabolic harm. They note questions about mechanisms, study limits, and a need for more trials.
Exercise better than protein powder for older adults' muscle strength
A clinical trial in people aged 65 and over found that extra protein from whey capsules did not increase muscle strength after 24 weeks. Researchers say resistance exercise remains the most reliable way to improve strength.